{"ticker": {"uuid": "a68e752a-0a33-460a-be88-5e5cfaea18de", "symbol": "8158", "name": "China Regenerative Medicine International Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Enterprise value to EBIT forward of China Regenerative Medicine International Limited \u2013 HKEX:8158", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPQnJpb19GcXdyOVpwbXJOSDN3MmMyenJGRHdtSlcxNGJyc0N2SEtnZjltLTQ0RGZOcUlqcDhITTd4bm1PVDBsaWVDMENNYk92cjg4Sm5CMEM1amtiRlR6Q3lvQWRXQVZ4dkZ0OFE5Q3I0cE5hQWpISzJnc2syTWhSUC1lSUVReFVzRE54SFoyeGwwbTcxVlY3eXVaNTdiak1nOXBlUEJFYmo?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T21:21:17+00:00", "published_display": "06 Jul 2026 21:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of China Regenerative Medicine International Limited \u2013 HKEX:8158", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOY21LbjdfNGxkRHJZZHpUdzFjLS1RYXpRYnlLd1JUSXFQdkduT3JqZzl1VFVqSUpULUItckxfNmtLMlhEN3ZoVnVmVWttaXdaeFBhaWgxMDR4OW90WkxsSjFpLXhuWGMzVUgzR1owd0FzLU8wSUU3V2Z1Qk5XYWF3b2dpcHJwV0lleEQ1ZjNkQmNBTjZFZXpTMDVjOA?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T17:31:48+00:00", "published_display": "06 Jul 2026 17:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Regenerative Medicine International Limited (Stock Code: 8158) and twelve of its current and former directors censured or criticised for breaching the GEM Listing Rules and the Director\u2019s Undertaking", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPVC1yVE9NMGRhS2J4MGFLSjZaZ29ocGM3cndVU2VwRldlVE03MnV2MU5INzRsdklkeEY1YmFKclhGR193VEZqanlhdUlpMEJCcTlUTGRxYVM4WlAzMjdfejhGbHp5bmlUSF9VdjF2UFZtdXdzaXhESi1CU0RudGdmaWVhSUlVNnc?oc=5", "source_name": "hkex.com.hk", "published_at": "2019-07-15T07:00:00+00:00", "published_display": "15 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQS-News: CRMI: China Regenerative Medicine International Limited Partner with University of Oxford and CCB International (Holdings) Limited Establishing a Strategic Platform for Industrialisation of Biomedical Research Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "TMX Newsfile", "published_at": "2015-10-22T07:00:00+00:00", "published_display": "22 Oct 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of China Regenerative Medicine International Limited \u2013 HKEX:8158", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPQnJpb19GcXdyOVpwbXJOSDN3MmMyenJGRHdtSlcxNGJyc0N2SEtnZjltLTQ0RGZOcUlqcDhITTd4bm1PVDBsaWVDMENNYk92cjg4Sm5CMEM1amtiRlR6Q3lvQWRXQVZ4dkZ0OFE5Q3I0cE5hQWpISzJnc2syTWhSUC1lSUVReFVzRE54SFoyeGwwbTcxVlY3eXVaNTdiak1nOXBlUEJFYmo?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T21:21:17+00:00", "published_display": "06 Jul 2026 21:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of China Regenerative Medicine International Limited \u2013 HKEX:8158", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOY21LbjdfNGxkRHJZZHpUdzFjLS1RYXpRYnlLd1JUSXFQdkduT3JqZzl1VFVqSUpULUItckxfNmtLMlhEN3ZoVnVmVWttaXdaeFBhaWgxMDR4OW90WkxsSjFpLXhuWGMzVUgzR1owd0FzLU8wSUU3V2Z1Qk5XYWF3b2dpcHJwV0lleEQ1ZjNkQmNBTjZFZXpTMDVjOA?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T17:31:48+00:00", "published_display": "06 Jul 2026 17:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Regenerative Medicine International Limited (Stock Code: 8158) and twelve of its current and former directors censured or criticised for breaching the GEM Listing Rules and the Director\u2019s Undertaking", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPVC1yVE9NMGRhS2J4MGFLSjZaZ29ocGM3cndVU2VwRldlVE03MnV2MU5INzRsdklkeEY1YmFKclhGR193VEZqanlhdUlpMEJCcTlUTGRxYVM4WlAzMjdfejhGbHp5bmlUSF9VdjF2UFZtdXdzaXhESi1CU0RudGdmaWVhSUlVNnc?oc=5", "source_name": "hkex.com.hk", "published_at": "2019-07-15T07:00:00+00:00", "published_display": "15 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQS-News: CRMI: China Regenerative Medicine International Limited Partner with University of Oxford and CCB International (Holdings) Limited Establishing a Strategic Platform for Industrialisation of Biomedical Research Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "TMX Newsfile", "published_at": "2015-10-22T07:00:00+00:00", "published_display": "22 Oct 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.28, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -11.1, "twelve_week_move": -9.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.103863, "market_dynamics_buy_signal": false, "relative_strength": -39.109184, "fair_value_gap": -35.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.9523, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -11.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 45, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "hkex.com.hk", "count": 1}, {"label": "TMX Newsfile", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -11.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of China Regenerative Medicine International Limited \u2013 HKEX:8158"}], "updated_at": "2026-07-18T02:10:33.563949+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}